Where is “Big Pharma” on the CBD explosion? What products have been approved, in development and being considered? What are the benefits and down-falls of pharmaceutical cannabis? The world of “Big Pharma” is changing for the better. What’s happening now could be the best opportunity for the public to disrupt the pharmaceutical business by buying a product that they have already shown the world they want to buy from vendors. Hemp-derived CBD and Big Pharma are on a collision course and the consumer will be the winner. In this episode we discuss all these changes and the future of CBD and what it will mean to consumers. For more information on this topic, listen to this podcast and then check out this article or one of our previous podcasts about his topic.
In today’s episode, we discuss how the Endocannabinoid System (ECS) has a significant impact on the bodies functions and how it can help with...
Who are the players and what are some recent moves in the cannabis and psychedelic regulatory landscape? Cannabis and psychedelics is a general term...
Doctors are having conversation and participating in Cannabis treatment therapies. In this episode we’ll share how to have this conversation and what you need...
